Health
FDA Approves Monthly Injectable HIV Drug Combo – Star Observer
The United States Food and Drug Administration on Thursday approved Cabenuva, for the treatment of HIV in adults.
The United States Food and Drug Administration on Thursday approved Cabenuva, a once a month injectable drug combination with cabotegravir and rilpivirine, for the treatment of HIV in adults.
Currently, the standard of care for patients with HIV includes patients taking daily pills to adequately manage their condition. This approval will allow some patients the option of receiving once-monthly injections in lieu of a daily oral treatment regimen, said Dr. John Farley, director of the Office of…
-
Noosa News23 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News24 hours agoMotorcyclist dies in crash with truck
-
Noosa News22 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
Business21 hours agoWhy this investing expert is calling time on NAB shares